Literature DB >> 15180522

Cullin-based ubiquitin ligase and its control by NEDD8-conjugating system.

Tomoki Chiba1, Keiji Tanaka.   

Abstract

Several studies have examined the importance of ubiquitin-like posttranslational modifiers (which consist of an unexpectedly large family). Of these, NEDD8 (also called Rub1, related to ubiquitin 1) with a high homology to ubiquitin is covalently linked to all members of cullin (Cul)-family proteins through an enzymatic cascade analogous to ubiquitylation. Cul-family proteins are scaffold proteins for a wide series of ubiquitin-protein ligase complexes, such as SCFs (Skp1, Cul-1, Roc1, and F-box proteins), which regulate the degradation of broad range of cellular proteins. Unlike ubiquitin, which mostly acts as a degradation signal for the target proteins, NEDD8 acts as an activation signal for Cul-family proteins; i.e., Cul-based ubiquitin-protein ligases. Accordingly, the NEDD8 conjugation pathway regulating Cul-protein function is responsible for a diverse array of biologically important processes, such as the cell cycle progression, signalling cascades and developmental programs. Furthermore, recent studies have revealed that the COP9/Signalosome complex interacts physically and genetically with Cul-family proteins, and catalyzes deconjugation of NEDD8 ligated to Cul-family proteins. This review summarizes recent advances in biochemical and genetic studies on how the NEDD8-modifying system regulates Cul-family proteins and their physiology.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15180522     DOI: 10.2174/1389203043379783

Source DB:  PubMed          Journal:  Curr Protein Pept Sci        ISSN: 1389-2037            Impact factor:   3.272


  31 in total

Review 1.  Oncogenic activation of NF-kappaB.

Authors:  Louis M Staudt
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04-21       Impact factor: 10.005

Review 2.  Weighing in on ubiquitin: the expanding role of mass-spectrometry-based proteomics.

Authors:  Donald S Kirkpatrick; Carilee Denison; Steven P Gygi
Journal:  Nat Cell Biol       Date:  2005-08       Impact factor: 28.824

Review 3.  DUBs at a glance.

Authors:  Keith D Wilkinson
Journal:  J Cell Sci       Date:  2009-07-15       Impact factor: 5.285

4.  JAB1 determines the response of rheumatoid arthritis synovial fibroblasts to tumor necrosis factor-alpha.

Authors:  Jianhua Wang; Chuanyu Li; Yuelong Liu; Wan Mei; Shaohua Yu; Cunren Liu; Liming Zhang; Xu Cao; Robert P Kimberly; William Grizzle; Huang-Ge Zhang
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

5.  Loss of the CONSTITUTIVE PHOTOMORPHOGENIC9 signalosome subunit 5 is sufficient to cause the cop/det/fus mutant phenotype in Arabidopsis.

Authors:  Esther M N Dohmann; Carola Kuhnle; Claus Schwechheimer
Journal:  Plant Cell       Date:  2005-05-27       Impact factor: 11.277

6.  Characterization of the VIER F-BOX PROTEINE genes from Arabidopsis reveals their importance for plant growth and development.

Authors:  Katja M Schwager; Luz Irina A Calderon-Villalobos; Esther M N Dohmann; Björn C Willige; Stephan Knierer; Carola Nill; Claus Schwechheimer
Journal:  Plant Cell       Date:  2007-04-13       Impact factor: 11.277

Review 7.  New and emerging therapies for acute myeloid leukaemia.

Authors:  Julian R Davis; David J Benjamin; Brian A Jonas
Journal:  J Investig Med       Date:  2018-08-19       Impact factor: 2.895

8.  NEDD8-targeting drug MLN4924 elicits DNA rereplication by stabilizing Cdt1 in S phase, triggering checkpoint activation, apoptosis, and senescence in cancer cells.

Authors:  Jie Jessie Lin; Michael A Milhollen; Peter G Smith; Usha Narayanan; Anindya Dutta
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

9.  Crystal structure of the human ubiquitin-activating enzyme 5 (UBA5) bound to ATP: mechanistic insights into a minimalistic E1 enzyme.

Authors:  John-Paul Bacik; John R Walker; Mohsin Ali; Aaron D Schimmer; Sirano Dhe-Paganon
Journal:  J Biol Chem       Date:  2010-04-05       Impact factor: 5.157

10.  An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer.

Authors:  Teresa A Soucy; Peter G Smith; Michael A Milhollen; Allison J Berger; James M Gavin; Sharmila Adhikari; James E Brownell; Kristine E Burke; David P Cardin; Stephen Critchley; Courtney A Cullis; Amanda Doucette; James J Garnsey; Jeffrey L Gaulin; Rachel E Gershman; Anna R Lublinsky; Alice McDonald; Hirotake Mizutani; Usha Narayanan; Edward J Olhava; Stephane Peluso; Mansoureh Rezaei; Michael D Sintchak; Tina Talreja; Michael P Thomas; Tary Traore; Stepan Vyskocil; Gabriel S Weatherhead; Jie Yu; Julie Zhang; Lawrence R Dick; Christopher F Claiborne; Mark Rolfe; Joseph B Bolen; Steven P Langston
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.